UCSF Helen Diller Family Comprehensive Cancer Center
Research facility
Location:
San Francisco, CA,
United States (USA) (US)
ISNI: 0000000404349023
ROR: https://ror.org/01t8svj65
Efficacy and Safety of Telotristat Ethyl in Patients With Carcinoid Syndrome Inadequately Controlled by Somatostatin Analogs: Analysis of the Completed TELESTAR Extension Period (2018)
Hoersch D, Kulke MH, Caplin ME, Anthony LB, Bergsland E, Oberg K, Warner RRP, et al.
Conference contribution
Weight Change Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome (2018)
Weickert MO, Kaltsas G, Hoersch D, Lapuerta P, Pavel ME, Valle JW, Caplin ME, et al.
Journal article
Evaluation of meaningful change in bowel move frequency for patients with carcinoid syndrome (2017)
Pavel ME, Gable J, Kulke MH, Bergsland E, Anthony LB, Caplin ME, Oberg KE, et al.
Conference contribution